CND10 CJC‑1295 Without DAC 10mg × 10 vials

$120.00

In stock

High-dose short‑acting CJC‑1295 Without DAC 10mg × 10 vials for advanced GH-axis research.

CND10 CJC-1295 Without DAC 10mg × 10 Vials 

CND10 CJC‑1295 Without DAC 10mg × 10 vials, also known as Modified GRF (1-29), is widely referenced in scientific and research discussions for its role in studying growth hormone–related pathways. The CND10 CJC-1295 Without DAC 10mg × 10 vials configuration is commonly used in laboratory settings where larger vial quantities and higher peptide amounts support extended or multi-phase experimentation.

This article provides a clear, research-focused overview intended purely for educational and informational purposes.

What Is CJC-1295 Without DAC?

CJC-1295 Without DAC is a short-acting Growth Hormone Releasing Hormone (GHRH) analogue.
It differs from the DAC version as it does not bind to albumin, resulting in:

  • A shorter half-life

  • More precise timing for studies

  • Clearer observation of pulsatile GH responses

Researchers often use CJC-1295 Without DAC to explore hormonal signaling, pituitary activity, and the mechanisms behind GH release.

CND10 CJC-1295 Without DAC 10mg × 10 Vials — Overview

1. Higher Research Volume

Each vial contains 10mg, suitable for studies requiring increased peptide quantity, multiple test cycles, or comparison across variables.

2. Consistency Across Experiments

Having 10 vials of the same specification allows researchers to maintain uniformity throughout a series of trials.

3. Flexible Study Design

Larger vials make it easier to conduct:

  • Multi-phase research

  • Comparative analysis

  • Repeated experiments

This format supports efficient planning and resource management.

Why Researchers Study CJC-1295 Without DAC

1. GH Pulse Dynamics

Because it is short-acting, researchers can investigate rapid and natural GH pulsation patterns.

2. Receptor Activity Evaluation

CJC-1295 Without DAC allows controlled exploration of GHRH receptor interactions and signaling effects.

3. Comparative Endocrine Studies

It is often compared with:

  • CJC-1295 with DAC

  • GHRP peptides

  • Other GHRH analogues

This helps in understanding similarities, differences, and structural impacts.

CJC-1295 Without DAC vs. DAC Version

Feature Without DAC With DAC
Half-Life Short Long
Albumin Binding No Yes
Research Use Pulsatile studies Long-duration GH activity
Alternate Name Modified GRF (1-29) CJC-1295 DAC

The choice depends entirely on study requirements and experimental timeframes.

Research Applications

CJC-1295 Without DAC is commonly referenced in:

  • Endocrine pathway investigation

  • Hormonal pulse studies

  • Peptide degradation analysis

  • Biochemical signaling research

  • Short-term pharmacokinetic modeling

It helps researchers better understand biological mechanisms involving GH regulation.

Storage & Handling (General Information Only)

  • Controlled temperature conditions

  • Sterile environments

  • Clearly labeled research documentation

Protocols may vary by institution.

Conclusion

The CND10 CJC-1295 Without DAC 10mg  format is valued in research environments that require consistency, larger study volume, and short-acting GHRH analogue analysis. By offering a higher vial content, it supports expanded scientific inquiry into GH pathway signaling and peptide behavior.

error: Content is protected !!

Main Menu